CRISPR-CasΦ from huge phages is a hypercompact genome editor
2020 · Science · 543 citations
https://doi.org/10.1126/science.abb1400
B
Brady F. Cress
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
63
Papers
3.3K
Citations
26
h-index
39
i10-index
Brady F. Cress is an academic researcher from Innovative Genomics Institute. The author has contributed to research in topics: CRISPR and Genetic Engineering & Bacteriophages and microbial interactions & Genomics and Phylogenetic Studies. The author has an h-index of 26, co-authored 54 publications.
ORCID: 0000-0002-2948-2846Papers by this author
worksCRISPRi-mediated metabolic engineering of E. coli for O-methylated anthocyanin production
2017 · Microbial Cell Factories · 151 citations
https://doi.org/10.1186/s12934-016-0623-3
Diverse virus-encoded CRISPR-Cas systems include streamlined genome editors
2022 · Cell · 138 citations
https://doi.org/10.1016/j.cell.2022.10.020
Broad-spectrum CRISPR-Cas13a enables efficient phage genome editing
2022 · Nature Microbiology · 111 citations
https://doi.org/10.1038/s41564-022-01258-x
Structural basis for AcrVA4 inhibition of specific CRISPR-Cas12a
2019 · eLife · 58 citations
https://doi.org/10.7554/elife.49110
Identification of the binding sites for ubiquinone and inhibitors in the Na+-pumping NADH-ubiquinone oxidoreductase from Vibrio cholerae by photoaffinity labeling
2017 · Journal of Biological Chemistry · 31 citations
https://doi.org/10.1074/jbc.m117.781393
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat